ACI HEALTHCARE USA, INC
CORAL SPRINGS, FLORIDA

ACI Healthcare USA is a new generic pharmaceutical company, a subsidiary of ACI Healthcare Ltd. in Bangladesh. The parent company of ACI Healthcare Ltd is ACI Limited, a leading conglomerate in Bangladesh engaged, in addition to pharmaceuticals, in consumer products, agricultural business, information technology and retail chain. The annual revenue for the ACI Group in 2015 is US$402 million. Although the name ACI Healthcare USA is new in the US generic pharmaceutical industry, the company has been supplying high quality, generic pharmaceuticals in the US via its partners. The goal of ACI Healthcare USA is to delivery significant value to consumers and to direct purchasers of the company’s products. The company plans to delivery this goal thru cost-effective manufacturing at its only-for-US, state-of the-art manufacturing facility in Bangladesh. To continue to increase the product portfolio of ACI Healthcare USA, the company has R&D operations at the Bangladesh site and in other parts of the world, including the US. Keeping its objective of delivering significant value to consumers, the company’s R&D activities range from developing run-of the-mill generic products to generic alternatives of technologically advanced, hard-to-replicate multi-billion dollar brands. ACI Healthcare USA is a new generic pharmaceutical company, a subsidiary of ACI Healthcare Ltd... ACI Healthcare USA is a new generic pharmaceutical company, a subsidiary of ACI Healthcare Ltd. in Bangladesh. The parent company of ACI Healthcare Ltd is ACI Limited, a leading conglomerate in Bangladesh engaged, in addition to pharmaceuticals, in consumer products, agricultural business, information technology and retail chain. The annual revenue for the ACI Group in 2015 is US$402 million. Although the name ACI Healthcare USA is new in the US generic pharmaceutical industry, the company has been supplying high quality, generic pharmaceuticals in the US via its partners. The goal of ACI Healthcare USA is to delivery significant value to consumers and to direct purchasers of the company’s products. The company plans to delivery this goal thru cost-effective manufacturing at its only-for-US, state-of the-art manufacturing facility in Bangladesh. To continue to increase the product portfolio of ACI Healthcare USA, the company has R&D operations at the Bangladesh site and in other parts of the world, including the US. Keeping its objective of delivering significant value to consumers, the company’s R&D activities range from developing run-of the-mill generic products to generic alternatives of technologically advanced, hard-to-replicate multi-billion dollar brands. Mission of ACI Healthcare USA The mission of ACI Healthcare USA is to deliver value of generic pharmaceuticals for consumers and payors. For our direct purchasers of products, to deliver high-quality, cost effective products with no or minimum supply interruptions. And to do all these keeping our parent company’s financial and corporate objectives in mind.